Results 11 to 20 of about 561,570 (286)
Humoral immunity in cancer [PDF]
Humoral immunity driven by B cells, plasma cells, and antibodies has emerged as a major determinant of tumor control, immune escape, and therapeutic response.
Jeanne Leonard +2 more
doaj +3 more sources
Humoral Immunity vs. Salmonella
In primary infection with Salmonella, it has been reported—without consideration of Salmonella's functions—that humoral immunity plays no role in the clearance of bacteria.
Koji Tokoyoda
exaly +3 more sources
Establishing humoral immunity to rabies in a person with multiple sclerosis through booster vaccination: A case report [PDF]
It is known that certain disease-modifying therapies for multiple sclerosis impair humoral immunity; however, data on the effect of therapies on humoral immunity with human diploid cell rabies vaccine is limited.
D Dinov +3 more
doaj +2 more sources
Timing of Assessment of Humoral and Cell-Mediated Immunity after Influenza Vaccination
Assessment of the immune response to influenza vaccines should include an assessment of both humoral and cell-mediated immunity. However, there is a lack of consensus regarding the timing of immunological assessment of humoral and cell-mediated immunity ...
Naruhito Otani +11 more
doaj +2 more sources
Immunity, life history and conservation in the Galapagos sea lion [PDF]
Infectious disease threatens health and biodiversity across the globe, and disease emergence may become more common as humans further encroach on habitats and modify environments. To assess the risks of disease emergence in natural populations accurately,
Brock, Patrick Michael
core +6 more sources
Structural insights into the biological functions of the long pentraxin PTX3
Soluble pattern recognition molecules (PRMs) are a heterogenous group of proteins that recognize pathogen- and danger-associated molecular patterns (PAMPs and DAMPs, respectively), and cooperate with cell-borne receptors in the orchestration of innate ...
Anna Margherita Massimino +4 more
doaj +1 more source
Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells
Broadly neutralizing antibodies (bNAbs) neutralize HIV-1 and exert Fc-dependent activities against infected cells. Here, Dufloo et al. show that bNAbs also block HIV-1 release by trapping viral particles at the surface of infected cells.
Jérémy Dufloo +11 more
doaj +1 more source
Immunity following infection and vaccination with the SARS-CoV-2 Omicron variant is poorly understood. The aim was to investigate immunity assessed with antibody response, neutralizing antibodies (NAbs), and IFN-γ release under different scenarios: in ...
Maria Skaalum Petersen +10 more
doaj +1 more source
Antibody Neutralization of HIV-1 Crossing the Blood-Brain Barrier
HIV-1 can cross the blood-brain barrier (BBB) to penetrate the brain and infect target cells, causing neurocognitive disorders as a result of neuroinflammation and brain damage.
Valérie Lorin +5 more
doaj +1 more source
Recurrent respiratory tract infections (RRTIs) are one of the most common pediatric diseases. Although the pathogenesis of pediatric RRTIs remains unknown, ineffective B cell-dominated humoral immunity has been considered as the core mechanism.
Jun Diao +3 more
doaj +1 more source

